Corteva, Inc. $CTVA Shares Sold by Brandywine Global Investment Management LLC

Brandywine Global Investment Management LLC reduced its position in Corteva, Inc. (NYSE:CTVA) by 1.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 474,136 shares of the company’s stock after selling 8,745 shares during the quarter. Brandywine Global Investment Management LLC’s holdings in Corteva were worth $31,781,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Hilton Head Capital Partners LLC purchased a new stake in shares of Corteva during the 4th quarter worth $44,000. ING Groep NV boosted its position in shares of Corteva by 74.8% during the 4th quarter. ING Groep NV now owns 83,780 shares of the company’s stock worth $5,616,000 after purchasing an additional 35,863 shares in the last quarter. Havemeyer Place LP purchased a new stake in shares of Corteva during the 4th quarter worth $207,000. MCF Advisors LLC boosted its position in shares of Corteva by 86.4% during the 4th quarter. MCF Advisors LLC now owns 2,837 shares of the company’s stock worth $190,000 after purchasing an additional 1,315 shares in the last quarter. Finally, First Command Advisory Services Inc. boosted its position in shares of Corteva by 113.3% during the 4th quarter. First Command Advisory Services Inc. now owns 1,039 shares of the company’s stock worth $70,000 after purchasing an additional 552 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Price Performance

NYSE:CTVA opened at $76.04 on Tuesday. The firm has a market cap of $50.86 billion, a price-to-earnings ratio of 44.73, a price-to-earnings-growth ratio of 2.36 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The company’s 50-day moving average is $81.03 and its two-hundred day moving average is $75.09. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CTVA. The Goldman Sachs Group boosted their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Jefferies Financial Group boosted their price objective on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. BNP Paribas Exane boosted their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Finally, Morgan Stanley boosted their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.